Omobolanle A Omoteso, Handsome Ndlovu, Sandile M Khamanga, Roderick B Walker
{"title":"The palatability of commercially available hyoscine butyl bromide syrups for paediatric use in South Africa: comparative assessment using an electronic tongue.","authors":"Omobolanle A Omoteso, Handsome Ndlovu, Sandile M Khamanga, Roderick B Walker","doi":"10.1080/10837450.2026.2626412","DOIUrl":"10.1080/10837450.2026.2626412","url":null,"abstract":"<p><p>Patient rejection of unpalatable products can adversely affect therapeutic adherence, potentially leading to treatment failure. Taste masking is a goal in pharmaceutical development, particularly when developing formulations for paediatric patients. The use of an electronic tongue (e-tongue) enables rapid, objective, and robust taste evaluation. Its use is gaining traction in the quality assessment of pharmaceutical products. The capability of an Alpha Astree II taste-sensing system to evaluate the palatability of commercially available hyoscine butylbromide (HBB) syrup brands in South Africa, was investigated. Principal component analysis (PCA) was used to process the e-tongue data and the resultant biplots can distinguish between the taste of reference compounds and HBB syrups. The sensor values and taste screening rankings indicate the three brands exhibit a bitter-sweet taste. Brand Z has greater bitterness and sourness than brands, X and Y due to citric acid monohydrate in the formulation. Brand Y included sodium cyclamate and was the most palatable syrup. The findings indicate the e-tongue can differentiate the taste of HBB syrups when different excipients are used to alter taste. Pharmaceutical companies could use these data to improve the palatability of currently available hyoscine syrups. The E-tongue is a complementary instrument to human sensory panels used to inform product development in alignment with customer preferences.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"428-442"},"PeriodicalIF":2.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146106810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yousef A Bin Jardan, Mustafa R Abdulbaqi, Sahar A M Omran, Fatma Youssef Ali Abbas, Asmaa Youssef A Abbas, Heba M Mohammed, Sulaf Ahmed Abdellatif, Hesham M Tawfeek
{"title":"<i>Lepidium sativum</i> and metformin hydrochloride hydrogels for effective management of wounds in an induced diabetic rat model.","authors":"Yousef A Bin Jardan, Mustafa R Abdulbaqi, Sahar A M Omran, Fatma Youssef Ali Abbas, Asmaa Youssef A Abbas, Heba M Mohammed, Sulaf Ahmed Abdellatif, Hesham M Tawfeek","doi":"10.1080/10837450.2026.2630171","DOIUrl":"10.1080/10837450.2026.2630171","url":null,"abstract":"<p><p>Diabetic wounds need effective and prompt treatment otherwise, it will be complicated with sever bacterial infections. In this study, hydrogels containing <i>Lepidium sativum</i> seeds aqueous extract (LS<sub>ae</sub>), metformin (MET) and combination (LS<sub>ae</sub> and MET) were prepared and characterized for their pH, contents, spreadability, viscosity, rheology, morphology, physical stability and <i>in vitro</i> release. Percentage of wound contraction in streptozotocin induced diabetic rats was studied. In addition, certain biochemical parameters, like tumor necrosis factor-alpha, TNF-α, interleukin, IL-6, malondialdehyde, MDA and matrix metalloproteinase-9, MMP-9 as inflammatory and oxidative stress biomarkers were quantified. Histopathological changes were studied and immunohistochemical staining was used to detect vascular endothelial growth factor, VEGF and platelet endothelial cell adhesion molecule-1, PECAM-1/CD31. Pharmaceutical characterization revealed the suitability of hydrogels for topical administration. Combination hydrogel group 2 showed a significant reduction in TNF-α, IL-6, MMP-9 and MDA (296.36 ± 16.31, 8.33 ± 1.06 pg/ml, 0.61 ± 0.35 ng/ml and 13.30 ± 1.4 nmol/ml) compared to other tested groups. Histopathological examination showed complete re-epithelization with granulation tissue formation and thicker well-organized collagen fibers for groups 1 and 2 after 7 days. However, LS<sub>ae</sub> hydrogel group 1 had a faster effect, a significant expression of VEGF (64.00 ± 17.08 positively stained cells) and (95.73 ± 2.4% wound contraction). It could be concluded that LS<sub>ae</sub> hydrogel is a promising formulation for effective rapid management of diabetic wounds.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"443-463"},"PeriodicalIF":2.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146166219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Synergistic combination of quercetin and kaempferol via milk exosome-based emulsion for enhanced antioxidant and anti-skin aging efficacy.","authors":"Xuemei Gu, Jie Wang, Jing Chen, Zhiyang Lv, Shaohua Wu, Bowen Li, Guanyu Liu, Xiaohui Wang, Tianye Qian, Yuhang Wu","doi":"10.1080/10837450.2026.2635734","DOIUrl":"10.1080/10837450.2026.2635734","url":null,"abstract":"<p><p>The natural flavonoids quercetin (Que) and kaempferol (Kae) show great potential for anti-aging applications but suffer from poor solubility and skin permeability. This study aimed to develop a synergistic topical emulsion system to overcome the poor bioavailability of the Que and Kae for enhanced efficacy. The optimal synergistic molar ratio (Que:Kae = 1:2) was first identified <i>via</i> 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging and cellular assays. The drugs were then loaded into milk-derived exosomes (mExo) using a Box-Behnken design (BBD), achieving high encapsulation (>69%), a size of ∼120 nm, and a polydispersity index (PDI) of 0.180. This complex was incorporated into an oil-in-water emulsion, with its formulation also BBD-optimized for stability. In a D-galactose-induced skin aging mouse model, the final Que/Kae-mExo@Eml formulation significantly outperformed control groups (free drug mixture, blank exosome emulsion, and vitamin C). It most effectively reduced oxidative stress (malondialdehyde, MDA), enhanced antioxidant enzymes (superoxide dismutase, SOD and glutathione, GSH), suppressed matrix metalloproteinase-1 (MMP-1), promoted collagen I (Col I) synthesis, and improved skin histology, elasticity, and hydration. In conclusion, an optimized, stable emulsion leveraging a synergistic 1:2 drug ratio and an mExo delivery system was successfully developed, demonstrating superior comprehensive efficacy against skin aging.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"464-480"},"PeriodicalIF":2.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147271521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rahul Jha, Arzoo Sekhani, Nikita Panchal, Pranav Shah
{"title":"Zoomlab™-guided co-crystal engineering of nilotinib for improved dissolution.","authors":"Rahul Jha, Arzoo Sekhani, Nikita Panchal, Pranav Shah","doi":"10.1080/10837450.2026.2624727","DOIUrl":"10.1080/10837450.2026.2624727","url":null,"abstract":"<p><p>Nilotinib (NH), a second-generation tyrosine kinase inhibitor for chronic myelogenous leukemia (CML), exhibits poor aqueous solubility and low intestinal permeability, classifying it as a Biopharmaceutics Classification System (BCS) Class IV drug. This study aimed to enhance NH solubility and dissolution through co-crystallization, guided by computational and experimental approaches. BASF's ZoomLab™ platform was utilized for rational coformer selection using the solubility parameter difference (Δδv) method. Validation with paracetamol and posaconazole datasets established 5 MPa<sup>0.5</sup> as the optimal Δδv threshold. Pyroglutamic acid (PG) emerged as the most suitable coformer and was co-crystallized with NH <i>via</i> liquid-assisted grinding (LAG). Solid-state characterization (PXRD, DSC, FTIR, SEM) confirmed formation of Nilotinib-Pyroglutamic acid co-crystal (NH-PGCC). The co-crystal displayed significantly improved wettability and a 3.23-fold increase in solubility in 0.1 N HCl compared to pure NH. Although rapid phase transformation occurred within 3 min, PEG 6K stabilized the supersaturated state, improving dissolution. The optimized NH-PGCC capsule achieved 75% drug release in 15 min, significantly outperforming marketed formulations (Tasigna<sup>®</sup> and Nilotirel<sup>®</sup>) and reduction of crystallinity was less than 2% in 6 months, suggesting stability of co-crystal. This study successfully demonstrates the applicability of ZoomLab™ in coformer prediction and formulation development for solubility enhancement of poorly soluble drugs.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"395-412"},"PeriodicalIF":2.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zeinab Hassan Gaafar, Suzan Fangary, Ahmed K B A W Farouk, Ahmed M Fatouh
{"title":"Galactosylated bilosomes for liver-targeted delivery of ledipasvir: optimization, conjugate synthesis, and cellular evaluation.","authors":"Zeinab Hassan Gaafar, Suzan Fangary, Ahmed K B A W Farouk, Ahmed M Fatouh","doi":"10.1080/10837450.2025.2611896","DOIUrl":"10.1080/10837450.2025.2611896","url":null,"abstract":"<p><p>Ledipasvir is one of the direct-acting antiviral agents used for treating hepatitis C virus (HCV) infection. To achieve dose reduction and cost-effective therapy, this study aimed to enhance the interaction of ledipasvir with HCV-infected hepatocytes through the development of cationic bilosomes (CBs) and galactosylated bilosomes (GBs). These delivery systems were designed to promote hepatocellular targeting <i>via</i> the asialoglycoprotein receptors (ASGPRs). Eight bilosomal formulations were developed by the ethanol injection method following a 2³ full factorial design, and numerical optimization using Design Expert<sup>®</sup> software identified the optimized formulation. In parallel, galactosylated stearylamine (GSA) was synthesized through conjugation of stearylamine (SA) with lactobionic acid (LB). The successful synthesis of GSA was verified through FTIR and <sup>1</sup>H NMR spectroscopic analyses. SA and GSA were subsequently incorporated into the optimized bilosomes to obtain CBs and GBs, respectively. The prepared systems were evaluated for particle size, polydispersity index, entrapment efficiency, and zeta potential, and their morphology was identified using transmission electron microscopy. Following 8-h incubation with HepG2 cells, CBs and GBs achieved significantly higher cumulative cellular uptake of ledipasvir (31.79% ± 3.11% and 20.62% ± 2.12%, respectively) compared to the ledipasvir free dispersion (11.02% ± 3.02%). These findings highlight CBs and GBs as promising nanocarriers for targeted delivery of ledipasvir to hepatocytes.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"199-210"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"<i>In vitro</i> antifungal and antibiofilm evaluation of reduction-responsive ketoconazole-loaded nanoparticles based on cystamine-modified poly (isobutene-alt-maleic anhydride) polymer.","authors":"Fuyou Wang, Qingmin Liu, Wenhui Wu, Yuxiao Su, Zhimei Song, Runliang Feng","doi":"10.1080/10837450.2026.2615155","DOIUrl":"10.1080/10837450.2026.2615155","url":null,"abstract":"<p><strong>Purpose: </strong>In order to develop reduction-responsive nano-drug delivery system for encapsulating antifungal drugs.</p><p><strong>Methods: </strong>Herein, with poly (isobutene-alt-maleic anhydride) as skeleton, we synthesized a polymer containing cross-linked disulfide bonds to prepare reduction-responsive ketoconazole-loaded nanoparticles (MPEG-P-KET). The <i>in vitro</i> reduction-responsive behavior and antifungal activity of MPEG-P-KET were investigated.</p><p><strong>Results: </strong>The MPEG-P-KET improved the dispersion and solubility of lipophilic KET. KET's imidazole group formed a salt with the free carboxyl groups in the polymer carrier, resulting in delayed drug release from MPEG-P-KET. However, MPEG-P-KET still exhibited reduction-sensitive drug release behavior, and showed comparable antifungal activity with KET <i>in vitro</i>. Interestingly, MPEG-P-KET demonstrated higher ability to inhibit biofilm formation and disrupt mature biofilms than KET.</p><p><strong>Conclusion: </strong>The polymeric nanoparticles with disulfide bonds could be used for the encapsulation and controlled delivery of antifungal drugs in the field of fungal infection treatment.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"253-266"},"PeriodicalIF":2.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145934347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fabrication and evaluation of felodipine push-pull osmotic pump capsule.","authors":"Chaowalit Monton, Poj Kulvanich","doi":"10.1080/10837450.2025.2608713","DOIUrl":"10.1080/10837450.2025.2608713","url":null,"abstract":"<p><p>Felodipine is traditionally delivered as extended-release tablets, but a push-pull osmotic pump (PPOP) capsule represents a promising alternative platform for controlled-release delivery. This work sought to characterize properties of the felodipine drug substance and crosslinked hard gelatin capsules (HGCs) for the preparation of the PPOP capsule. Additionally, drug release profiles of felodipine PPOP capsules under various formulation and medium conditions were investigated. Felodipine drug substances and crosslinked HGCs were evaluated for their physicochemical properties. Moreover, the type of release medium, number of Corelease CA coating rounds, amounts of Polyox WSR N80 and Polyox WSR Coagulant, sodium chloride content, and source of the drug substance were studied. Results showed that the physicochemical properties of felodipine drug substances exhibited statistically significant but minor variations between the two sources. Crosslinked HGCs remained insoluble in all tested media and exhibited spectral changes consistent with formaldehyde-induced crosslinking. Drug release approached Higuchi's kinetics when the formulation comprised 10 mg felodipine from a specific manufacturer, 120 mg of Polyox WSR N80, 35 mg of Polyox WSR Coagulant, and 20 mg of sodium chloride, with 10 coating rounds of Corelease CA and 1% sodium lauryl sulfate as the release medium. In conclusion, these findings highlight the significant influence of formulation parameters on drug-release behavior and provide a basis for developing PPOP capsules with consistent and predictable performance.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"183-198"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145820394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hydrogel nanoparticles of retinol acetate <i>via</i> modified rapid expansion of supercritical solution: design, optimization, and anticancer evaluation.","authors":"Milind Velhal, Jyotiram Sawale","doi":"10.1080/10837450.2026.2614360","DOIUrl":"10.1080/10837450.2026.2614360","url":null,"abstract":"<p><p>Polymeric nanoparticles are promising drug carriers due to their biocompatibility, sustained release, and improved therapeutic efficacy; however, conventional fabrication methods often suffer from broad size distribution, low encapsulation efficiency, and instability. To address these limitations, Sonication Assisted Particle Production using Supercritical Solution (SAPSS®), a modified RESS technique integrating ultrasonication and mechanical mixing, was developed to prepare and optimize HPMC K-100M hydrogel nanoparticles encapsulating retinol acetate using DOE, RSM, and ANOVA. The optimized formulation (retinol acetate: HPMC K-100M, 1:1 w/w) produced at 290 bar and 75 °C for 45 min with 1% Tween 80 yielded nanoparticles of 138.6 ± 1 nm, PDI 0.583 ± 0.03, zeta potential -14.9 ± 2.0 mV, encapsulation efficiency 99.02 ± 0.2%, and yield 66.4 ± 0.3%. FTIR, DSC, and XRD confirmed amorphous encapsulation and drug-polymer interactions, while SEM demonstrated spherical, discrete morphology. <i>In vitro</i> release studies revealed sustained drug release across physiological pH, with mucoadhesive strength supporting gastrointestinal retention. Cytotoxicity assays on COLO-205 cells, doxorubicin showed >90% cytotoxicity, free retinol acetate caused only 10-25% cell death, while HPMC-encapsulated retinol acetate nanoparticles produced enhanced, dose-dependent cytotoxicity of 25%, 35%, and 55% at 100, 200, and 300 µg/mL, respectively, with negligible toxicity from blank HPMC. Overall, SAPSS® provides a green, scalable approach for fabricating stable therapeutic nanoparticles.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"233-252"},"PeriodicalIF":2.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clobetasol propionate loaded nanostructured lipid carrier gel: formulation strategy and in vitro performance evaluation.","authors":"Mine Diril, Esra Karataş, H Yeşim Karasulu","doi":"10.1080/10837450.2026.2615158","DOIUrl":"10.1080/10837450.2026.2615158","url":null,"abstract":"<p><p>Clobetasol propionate (CP) is a potent Class I corticosteroid widely used to treat dermatological conditions; however, its poor aqueous solubility limits bioavailability. In this study, a nanostructured lipid carrier (NLC)-based gel was developed <i>via</i> the microemulsion method to improve the topical delivery of CP. The formulation was optimized using stearic acid (solid lipid), Captex 300 (liquid lipid), Tween 20 and Span 80 (surfactants), and propylene glycol (co-surfactant), based on solubility and thermodynamic stability assessments. Vitamin E acetate was incorporated as an antioxidant to inhibit lipid oxidation and enhance formulation stability. The optimized CP-NLC (F5) formulation had a particle size of 75.96 ± 4.87 nm, a zeta potential of -23.88 ± 4.10 mV, and a polydispersity index (PDI) of 0.27 ± 0.11. Encapsulation efficiency was 93.72 ± 0.26%, and drug loading reached 100.69 ± 0.62%. Transmission electron microscopy (TEM) confirmed spherical morphology. The gel (CP-NLC-F5-G) prepared with Carbopol 934 demonstrated a pH of 5.58 ± 0.68 and drug content uniformity of 99.03 ± 1.18%. <i>In vitro</i> release studies using Franz diffusion cells revealed sustained CP release compared to a commercial product. Stability studies indicated long-term encapsulation retention, attributed to the antioxidant effect of Vitamin E acetate. These findings suggest the potential of CP-NLC systems for effective, sustained corticosteroid delivery with enhanced dermal retention.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"267-281"},"PeriodicalIF":2.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146011688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Areej Eskandrani, Sara H Akl, Yahya H Shahin, Bassma H Elwakil, Keshav Raj Paudel, Amira Abd-Elfattah Darwish, Esraa A Moneer
{"title":"Nanostructured lipid nanoparticles delivering berberine with Se coating: a new nanotherapeutic approach against cryptosporidiosis.","authors":"Areej Eskandrani, Sara H Akl, Yahya H Shahin, Bassma H Elwakil, Keshav Raj Paudel, Amira Abd-Elfattah Darwish, Esraa A Moneer","doi":"10.1080/10837450.2026.2620476","DOIUrl":"10.1080/10837450.2026.2620476","url":null,"abstract":"<p><p>Berberine (BBR) exhibits broad antimicrobial and metabolic activities but suffers from limited bioavailability. Nanostructured lipid carriers (NLCs) can enhance oral delivery, while selenium (Se) coating may synergistically improve hypoglycemic and antiparasitic effects. This study aimed to design and evaluate the selenium-doped, berberine-loaded nanostructured lipid carriers (BBR-SeNLCs) for enhanced absorption, tissue diffusion, and antiparasitic efficacy against <i>Cryptosporidium parvum</i> in an immunosuppressed mouse model. BBR-SeNLCs were prepared <i>via</i> hot-melt dispersion/homogenization, followed by <i>in situ</i> reduction to deposit elemental selenium on the nanoparticle surface. A <i>Cryptosporidium</i> murine infection model was established. Parasitological burden (oocyst shedding), biochemical markers (ALT and AST), immunological parameters (IFN-γ, TNF-α, IL-6, and IL-10), and TEM ultrastructure of intestinal tissues were assessed. BBR-SeNLCs demonstrated successful berberine encapsulation. Among treatments, BBR-SeNLCs achieved comparable antiparasitic effects, with a notable reduction in oocyst shedding relative to infected controls. Biochemical assays indicate formulation-dependent hepatoprotective trends, particularly in BBR-SeNLCs formulations. Immunologically, Se-containing groups (Se alone and BBR-SeNLCs) displayed a shift toward moderated inflammatory responses (reduced IFN-γ, TNF-α, IL-6) with preserved or enhanced anti-inflammatory IL-10, suggesting balanced host immunity. Parasitological and ultrastructural analyses corroborated these findings, with BBR-SeNLCs showing preserved intestinal architecture and reduced parasite burden in treated groups.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"324-337"},"PeriodicalIF":2.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146019027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}